Product Information
TRIJARDY XR 5-2.5-1,000 MG TAB is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $5.6644 per EA under NDC 00597039523. Its NADAC has been published 218 times since Jun 22, 2022.
FDA first approved this application on Jan 27, 2020.
Strength
5; 2.5; 1000 mg/1; mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597039523
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212614FDA Approved
1/27/2020
On Market Since
4/23/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIJARDY XR 5-2.5-1,000 MG TAB has been published 218 times since Jun 22, 2022, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6644 per EA |
|---|---|
| All-time high | $10.1459 (Dec 31, 2025) |
| All-time low | $5.6418 (Jan 7, 2026) |
| 52-week high | $10.1459 |
| 52-week low | $5.6418 |
| Median price | $9.5110 |
| Average price | $9.1015 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 218 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIJARDY XR 5-2.5-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TRIJARDY XR 5-2.5-1,000 MG TAB, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $5.6644 per EA (NDC 00597039523), effective Aug 19, 2026.
How has the price of TRIJARDY XR 5-2.5-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for TRIJARDY XR 5-2.5-1,000 MG TAB has declined 37.9%. It has been tracked across 218 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for TRIJARDY XR 5-2.5-1,000 MG TAB?
Since Jun 22, 2022, the NADAC for TRIJARDY XR 5-2.5-1,000 MG TAB has ranged from a low of $5.6418 (Jan 7, 2026) to a high of $10.1459 (Dec 31, 2025), with a median of $9.5110 per EA.
Are there cheaper alternatives to TRIJARDY XR 5-2.5-1,000 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIJARDY XR 5-2.5-1,000 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIJARDY XR 5-2.5-1,000 MG TAB?
TRIJARDY XR 5-2.5-1,000 MG TAB (NDC 00597039523) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.